The Food and Drug Administration (FDA) has granted Fast Track designation to PP-01 (nabilone/gabapentin) for the mitigation of cannabis withdrawal symptoms in patients with cannabis use disorder.

Cannabis withdrawal symptoms ... Track Designation The FDA’s Fast Track designation allows for an accelerated review and development process for drugs targeting serious conditions with unmet ...